AKT1 and breast carcinoma: Additionally, they have proposed that the IGF-MAPK/ERK1/2-VEGF-C and IGF-1-PI3K/Akt-VEGF-C signaling pathways are crucial for lymph angiogenesis in breast cancer [59].